Good news for Celebrex, Bextra, and Vioxx

While the painkillers Celebrex, Bextra, and Vioxx significantly increase the risk of cardiovascular problems, the danger is not great enough to justify taking the drugs off the market, according to an advisory committee of the Food and Drug Administration. The advisory committee voted on whether to stop sales of the drugs Friday during a third and final day of considering the risks associated with taking Cox II selective non-steroidal anti-inflammatory drugs (NSAIDs). The committee recommended the FDA take certain actions to warn consumers about Celebrex, including a ban on direct marketing to consumers, a patient guide the drug, and a black box warning -- the highest level of warning that can go on a label -- which will address the cardiovascular risks of taking the medication. The article did not mention what was going to happen to all the lawsuits that are being filed against the makers of these drugs. I bet alot of lawyers were upset with this outcome.

Most of this article taken from CNN.com.